HSPA5 and gastric cancer: The AUC of anti-GRP78 antibody for GC patients in test group and GC patients in validation group were 0.718 (95% CI: 0.657 to 0.779) and 0.666 (95% CI: 0.623 to 0.710) (Figures 4(a) and 4(b)).